Precision Medicine News and Research

RSS

Novel peptide receptor radionuclide therapy improves wellbeing of neuroendocrine cancer patients

Malignant neuroendocrine tumors, commonly called NETs, are easy to miss and associated with discouraging survival rates and poor quality of life.

13 Jun 2017

Hybrid molecular imaging system detects vulnerable arterial plaques in earliest stages

A new study shows that a hybrid molecular imaging system unites three imaging modalities to map the composition of dangerous arterial plaques before they rupture and induce a major cardiac event.

12 Jun 2017

Researchers uncover molecule in newborn hearts that appears to control renewal process

Heart disease remains the leading cause of death worldwide, yet the few available treatments are still mostly unsuccessful once the heart tissue has suffered damage.

9 Jun 2017

Researchers find new way to improve T-cell therapy for treating cancer

Scientists have armed immune cells with a new surface molecule. This causes the cells to respond particularly aggressively when they encounter a protein that tumors actually use to camouflage themselves from the immune system.

8 Jun 2017

Mammography: Early breast cancer detection could lead to overdiagnosis

An analysis of breast cancer data revealed that many small breast cancers have an excellent prognosis because they are inherently slow growing, according to Yale Cancer Center experts.

8 Jun 2017

Exposure to medical imaging radiation does not increase child’s cancer risk

In an article published in the June 2017 issue of The Journal of Nuclear Medicine, researchers assert that exposure to medical imaging radiation not only doesn't increase an adult person's risk of getting cancer, it doesn't increase a child's risk.

7 Jun 2017

Two-pronged algorithm may prove to be accurate tool for predicting response to checkpoint inhibitors

The class of immunotherapies known as checkpoint inhibitors have proven to be a highly effective and advantageous treatment option for many cancer patients, but they don't work well for everyone, and oncologists have no reliable way to determine in advance which patients are likely to respond to these drugs.

7 Jun 2017

Focus on single sex threatens to limit impact of research findings, says Tulane endocrinologist

Over the last decade, many drugs that have been pulled from the market due to toxicity were withdrawn because they affected women more than men.

7 Jun 2017

New immunotherapy sends multiple myeloma into remission

Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.

6 Jun 2017

New targeted oral therapy results in durable responses across many kinds of cancer

Scientists may have developed the first targeted, oral, tumor-type agnostic therapy - a cancer medicine that works comparably well across many kinds of cancer, regardless of patient age. In clinical trials of adults and children with 17 different types of advanced cancer, larotrectinib treatment resulted in responses in 76% of patients.

5 Jun 2017

Genetic sequencing could help direct treatment for 72% of advanced cancer patients

A new analysis finds that nearly three-quarters of 500 patients with advanced cancer could be referred to a potential targeted treatment based on the results of a comprehensive analysis of their tumor's genetic landscape.

2 Jun 2017

CLI could be promising technique for assessing tumor margins during breast-conserving surgery

Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries.

1 Jun 2017

Penn State researchers show possible link between partial meltdown at TMI and thyroid cancers

Penn State College of Medicine researchers have shown, for the first time, a possible correlation between the partial meltdown of the Three Mile Island Nuclear Generating Station and thyroid cancers in the counties surrounding the plant.

1 Jun 2017

Moffitt researchers hope to improve personalized radiation therapy for head and neck cancer patients

Radiation therapy is one of the most common treatments used to fight cancer, with an estimated 500,000 people each year receiving radiation therapy either alone or in combination with other treatments.

31 May 2017

Researchers make significant advance in treatment of bowel cancer

New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.

31 May 2017

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a positive final Local Coverage Determination to expand Medicare coverage of the Prolaris test.

29 May 2017

New therapeutic approach could save diabetics from amputation by promoting wound healing

Diabetic patients frequently have lesions on their feet that are very difficult to heal due to poor blood circulation. In cases of serious non-healing infections, a decision to amputate could be made. A new therapeutic approach, presented recently in the Journal of Investigative Dermatology by Canadian researchers affiliated with the University of Montreal Hospital Research Centre, could prevent these complications by promoting wound healing.

29 May 2017

Precision Medicine News and Research

Novel peptide receptor radionuclide therapy improves wellbeing of neuroendocrine cancer patients

Hybrid molecular imaging system detects vulnerable arterial plaques in earliest stages

Researchers uncover molecule in newborn hearts that appears to control renewal process

Researchers find new way to improve T-cell therapy for treating cancer

Mammography: Early breast cancer detection could lead to overdiagnosis

Exposure to medical imaging radiation does not increase child’s cancer risk

Two-pronged algorithm may prove to be accurate tool for predicting response to checkpoint inhibitors

Focus on single sex threatens to limit impact of research findings, says Tulane endocrinologist

New immunotherapy sends multiple myeloma into remission

New targeted oral therapy results in durable responses across many kinds of cancer

Genetic sequencing could help direct treatment for 72% of advanced cancer patients

CLI could be promising technique for assessing tumor margins during breast-conserving surgery

Penn State researchers show possible link between partial meltdown at TMI and thyroid cancers

Moffitt researchers hope to improve personalized radiation therapy for head and neck cancer patients

Researchers make significant advance in treatment of bowel cancer

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

New therapeutic approach could save diabetics from amputation by promoting wound healing

Dragon Master Foundation to fund DIPG trial that will make patient data available live in the cloud

Study examines relationship between statin use and heart structure, function

Study finds wearable fitness trackers accurately measure heart rate but not energy expenditure

Editorial Focus eBook - Proteomics eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News